EmitBio: Funding, Investors & Team (Oct 2026)
A biotechnology business called EmitBioTM is developing products that are in the discovery, pre-clinical, and clinical stages. The Company's proprietary technology platform stimulates physiological signals and starts cellular repair by using carefully tailored light. Although initially concentrated on a COVID-19 at-home treatment, EmitBio aims to use a series of products to change the accepted standard of care for respiratory disease. KNOW Bio, LLC's operating company EmitBio Inc. is based in Durham, North Carolina.
EmitBio has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Nov 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
EmitBio Company Profile and Key Stats
Latest funding round on record: Nov 2022.
EmitBio Funding Rounds
EmitBio Founders and Leadership Team
No contact details are on record for this team yet.
EmitBio Funding Compared to Other Biotechnology Startups
EmitBio's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like EmitBio in Biotechnology and Durham
Companies Similar to EmitBio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
EmitBio Funding FAQs
What does EmitBio do?
A biotechnology business called EmitBioTM is developing products that are in the discovery, pre-clinical, and clinical stages. The Company's proprietary technology platform stimulates physiological signals and starts cellular repair by using carefully tailored light. Although initially concentrated on a COVID-19 at-home treatment, EmitBio aims to use a series of products to change the accepted standard of care for respiratory disease. KNOW Bio, LLC's operating company EmitBio Inc. is based in Durham, North Carolina.
How much funding has EmitBio raised?
EmitBio has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Nov 2022.
When did EmitBio last raise funding?
EmitBio's most recent funding round on record is an undisclosed round of $2.0M, announced in Nov 2022.
Who is the CEO of EmitBio?
David Emerson is listed as CEO at EmitBio.
Where is EmitBio headquartered?
EmitBio is based in Durham, North Carolina, United States.
How many employees does EmitBio have?
EmitBio is in the 11-50 employee band.
How does EmitBio's funding compare to other Biotechnology startups?
EmitBio's latest round of $2.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's EmitBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EmitBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.